Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rexall Osteo-Bi-Flex sees $5 mil. in initial sales; overall sales jump 54% in quarter.

This article was originally published in The Tan Sheet

Executive Summary

SUNDOWN OSTEO-BI-FLEX INITIAL SALES OF $5 MIL. were recorded in the fourth quarter ended Aug. 31. Shipped in mid-May, the patented glucosamine and chondroitin formula for osteoarthritis and "creaky joints" was supported by approximately $1.2 mil. in ad spending over the three-month period, with a total of $5 mil. earmarked for the product, Rexall Sundown said Oct. 15. The print and television campaign is scheduled to continue through the first quarter of 1998. Osteo-Bi-Flex is Rexall's first product to be supported by a national advertising campaign ("The Tan Sheet" May 5, p. 15).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel